Wei Xin1, Shuhua Mi2, Zhiqin Lin3, Hui Wang3, Wei Wei4. 1. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China. 2. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China. Electronic address: mishuhuaaz@163.com. 3. Department of Cardiovascular Medicine, Affiliated Hospital of Guiyang Medical College, Guizhou, China. 4. Department of Pathophysiology, Medical School of Nankai University, Tianjin, China.
Abstract
OBJECTIVE: To quantitatively estimate the prospective associations between orthostatic hypotension (OH) and cardiovascular diseases, including coronary heart disease (CHD) and stroke. METHODS: Relevant prospective cohort studies were identified by searching of Medline and Embase databases. We applied fixed or random effect model to estimate the overall effects depending on the heterogeneity among the included studies. RESULTS: Eight published articles from 7 cohorts, consisting of 64,782 participants, were included. During a mean follow-up of 15.2years, 5719 CHD events and 3657 stroke events occurred. The overall results of the meta-analysis indicated that OH was associated with significant increased risk for incident CHD (adjusted hazard ratio [HR]: 1.32, 95% confidence interval [CI]: 1.12-1.56) and stroke (HR: 1.19, 95% CI 1.08-1.30), which were independent of conventional risk factors. Stratified analyses by ages suggested that the associations between OH and CHD and stroke were significant for both the middle-aged and the old participants. CONCLUSION: Presence of OH was independently related to significantly increased risk for incidence of CHD and stroke. Further, studies regarding the mechanisms and potential treatments for OH may be important for understanding whether the associations between OH and cardiovascular diseases are causative.
OBJECTIVE: To quantitatively estimate the prospective associations between orthostatic hypotension (OH) and cardiovascular diseases, including coronary heart disease (CHD) and stroke. METHODS: Relevant prospective cohort studies were identified by searching of Medline and Embase databases. We applied fixed or random effect model to estimate the overall effects depending on the heterogeneity among the included studies. RESULTS: Eight published articles from 7 cohorts, consisting of 64,782 participants, were included. During a mean follow-up of 15.2years, 5719 CHD events and 3657 stroke events occurred. The overall results of the meta-analysis indicated that OH was associated with significant increased risk for incident CHD (adjusted hazard ratio [HR]: 1.32, 95% confidence interval [CI]: 1.12-1.56) and stroke (HR: 1.19, 95% CI 1.08-1.30), which were independent of conventional risk factors. Stratified analyses by ages suggested that the associations between OH and CHD and stroke were significant for both the middle-aged and the old participants. CONCLUSION: Presence of OH was independently related to significantly increased risk for incidence of CHD and stroke. Further, studies regarding the mechanisms and potential treatments for OH may be important for understanding whether the associations between OH and cardiovascular diseases are causative.
Authors: Justin Centi; Roy Freeman; Christopher H Gibbons; Sandy Neargarder; Alexander O Canova; Alice Cronin-Golomb Journal: Neurology Date: 2016-11-30 Impact factor: 9.910
Authors: Rianne A A de Heus; Daan L K de Jong; Anne Rijpma; Brian A Lawlor; Marcel G M Olde Rikkert; Jurgen A H R Claassen Journal: J Gerontol A Biol Sci Med Sci Date: 2020-10-15 Impact factor: 6.053
Authors: Artaza Gilani; Sheena E Ramsay; Stephen P Juraschek; Olia Papacosta; Lucy T Lennon; Peter H Whincup; Sasiwarang Goya Wannamethee Journal: J Clin Hypertens (Greenwich) Date: 2020-08-16 Impact factor: 3.738
Authors: Richard Migisha; David Collins Agaba; Godfrey Katamba; Jennifer Manne-Goehler; Anthony Muyingo; Mark J Siedner Journal: BMC Cardiovasc Disord Date: 2021-04-27 Impact factor: 2.298